| Eribulin investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 75show all (up to 200) |
|---|
| → investigated in trials for | Malignant Breast Neoplasmcancer_family 80 trials (20 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 80 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Neoplasmcancer_family 26 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triple-Negative Breast Carcinomamolecular_subtype 20 trials (8 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Triple-Negative Breast Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Soft Tissue Sarcoma 8 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Soft Tissue Sarcoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 8 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bladder Urothelial Carcinoma 4 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Bladder Urothelial Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Carcinoma 4 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Liposarcomasubtype 4 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Liposarcoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Non-Small Cell Carcinomasubtype 4 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Solid Neoplasm 4 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ovarian Carcinoma 4 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Ovarian Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sarcomacancer_family 4 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Sarcoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adult Solid Neoplasm 3 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Adult Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Inflammatory Carcinomasubtype 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Inflammatory Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HER2-Positive Breast Carcinoma 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | HER2-Positive Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |